JPS5675428A - Hypoglycemic agent containing procainamide hydrochloride - Google Patents
Hypoglycemic agent containing procainamide hydrochlorideInfo
- Publication number
- JPS5675428A JPS5675428A JP15162979A JP15162979A JPS5675428A JP S5675428 A JPS5675428 A JP S5675428A JP 15162979 A JP15162979 A JP 15162979A JP 15162979 A JP15162979 A JP 15162979A JP S5675428 A JPS5675428 A JP S5675428A
- Authority
- JP
- Japan
- Prior art keywords
- procainamide hydrochloride
- agent containing
- hypoglycemic
- formula
- active constituent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
PURPOSE: A hypoglycemic agnet with low toxicity, administrable for a long term preferably per os, and containing procainamide hydrochloride as an active constituent.
CONSTITUTION: A hypoglycemic agent containing procainamide hydrochloride of the formula as an active constituent. The compound of the formula well known as a remedy for arrythmia has been found to have also hypoglycemic action, and is administrable for a long term with low toxicity. The compound of the formula may have any administration form, preferably oral one. The daily dose of the active constituent for a man is 2W120mg/kg, preferably 10W60mg/kg.
COPYRIGHT: (C)1981,JPO&Japio
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15162979A JPS5675428A (en) | 1979-11-21 | 1979-11-21 | Hypoglycemic agent containing procainamide hydrochloride |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15162979A JPS5675428A (en) | 1979-11-21 | 1979-11-21 | Hypoglycemic agent containing procainamide hydrochloride |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5675428A true JPS5675428A (en) | 1981-06-22 |
| JPS5741443B2 JPS5741443B2 (en) | 1982-09-03 |
Family
ID=15522710
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP15162979A Granted JPS5675428A (en) | 1979-11-21 | 1979-11-21 | Hypoglycemic agent containing procainamide hydrochloride |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5675428A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013043925A1 (en) * | 2011-09-21 | 2013-03-28 | Gilead Sciences, Inc. | Sodium channel blockers reduce glucagon secretion |
| US9403782B2 (en) | 2011-05-10 | 2016-08-02 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| US9676760B2 (en) | 2011-07-01 | 2017-06-13 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| WO2018037103A1 (en) * | 2016-08-26 | 2018-03-01 | Idogen Ab | Procainamide for treating immune disorders and for modulating ido expression |
-
1979
- 1979-11-21 JP JP15162979A patent/JPS5675428A/en active Granted
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9403782B2 (en) | 2011-05-10 | 2016-08-02 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| US9682998B2 (en) | 2011-05-10 | 2017-06-20 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| US9676760B2 (en) | 2011-07-01 | 2017-06-13 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| WO2013043925A1 (en) * | 2011-09-21 | 2013-03-28 | Gilead Sciences, Inc. | Sodium channel blockers reduce glucagon secretion |
| WO2018037103A1 (en) * | 2016-08-26 | 2018-03-01 | Idogen Ab | Procainamide for treating immune disorders and for modulating ido expression |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5741443B2 (en) | 1982-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES8506567A1 (en) | Beta, gamma-dihydropolyprenyl alcohol derivatives and pharmaceutical composition containing a polyprenyl compound | |
| JPS5551020A (en) | Remedy for rheumatism | |
| JPS57109721A (en) | Carcinostatic agent | |
| JPS5675428A (en) | Hypoglycemic agent containing procainamide hydrochloride | |
| JPS57140716A (en) | Antiallergic agent | |
| JPS57114512A (en) | Antidia beticagent comprising (3-dimethyl-carbamoxy- phenyl)trimethyl ammonium derivative | |
| JPS5675427A (en) | Antiarteriosclerotic agent containing procainamide hydrochloride | |
| JPS5675432A (en) | Antitumor agent containing ethyl piperidylacetylaminobenzoate | |
| JPS56115715A (en) | Physiologically active agent containing (3- dimethylcarbam-oxyphenyl) trimethyl ammonium derivative | |
| JPS5731616A (en) | Relaxing agent for muscle comprising benzofurancarboxylic acid amide | |
| JPS5675430A (en) | Antiarteriosclerotic agent containing ethyl piperidylacetylaminobenzoate | |
| JPS5675431A (en) | Hypoglycemic agent containing ethyl piperidylacetylaminobenzoate | |
| JPS53127432A (en) | Novel physiologically active substance, anthglutin, and its preparation | |
| JPS5668611A (en) | Novel antiallergic agent | |
| JPS5536454A (en) | Novel immunosuppressive agent | |
| JPS5675429A (en) | Anti-inflammatory agent containing ethyl piperidylacetylaminobenzoate | |
| JPS5742620A (en) | Novel antiulcer agent | |
| JPS57128625A (en) | Carcinostatic | |
| JPS5675425A (en) | Antitumor agent containing procainamide hydrochloride | |
| JPS5675426A (en) | Anti-inflammatory agent containing procainamide hydrochloride | |
| JPS568317A (en) | Preventive and remedy for complicating disease of diabetes mellitus | |
| JPS5639018A (en) | Remedy for cancer | |
| JPS57126418A (en) | Antiallergic agent | |
| JPS54105237A (en) | Analgesic agent containing nalorphine-6-glucuronide | |
| JPS5569510A (en) | Carcinostatic agent |